Omnicin Therapeutics
PrivateLast Round
Grant
Feb 1, 2020
Company Overview
Omnicin Therapeutics operates in Healthcare & Life Sciences and is based in Groningen. Its latest recorded funding round was a Grant round in February 2020.
Omnicin Therapeutics is a pharmaceutical company that develops inhaled therapeutic platforms designed to restore antibiotic sensitivity in multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omnicin Therapeutics Comparables
Compare Omnicin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Helperby Therapeutics | 79% | |
| Revagenix, Inc. | 77% | |
| Spexis AG | 77% |
For institutional investors. Book with your work email.
Omnicin Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Omnicin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Accelerator |
| Netherlands Organization for Scientific Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2020
Received grant from Netherlands Organization for Scientific Research.
For institutional investors. Book with your work email.
Omnicin Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Omnicin Therapeutics's valuation, stock price, and market status.
Is Omnicin Therapeutics a public or private company?
Omnicin Therapeutics is a private company.
What is the current stock price of Omnicin Therapeutics?
Omnicin Therapeutics is a private company, so its shares have no public market price. Caplight tracks Omnicin Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Omnicin Therapeutics worth (valuation)?
Valuation information for Omnicin Therapeutics is not publicly available.
Can I buy Omnicin Therapeutics stock?
Omnicin Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Omnicin Therapeutics's last funding round?
Omnicin Therapeutics's most recent funding round was Grant on February 1, 2020.
Who are the main investors in Omnicin Therapeutics?
Key investors in Omnicin Therapeutics include INCATE, Netherlands Organization for Scientific Research.
Will Omnicin Therapeutics IPO soon?
No public IPO plans have been announced for Omnicin Therapeutics.
How can I track Omnicin Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Omnicin Therapeutics's shares on secondary markets.